Glossary / Clinical Evidence / Open-label extension

Open-label extension

A continuation phase after the controlled part of a trial, where everyone knows they are receiving the compound. Useful for long-term safety, weak as efficacy evidence, because the blinding is gone.

A continuation phase after the controlled part of a trial, where everyone knows they are receiving the compound. Useful for long-term safety, weak as efficacy evidence, because the blinding is gone.

Stay current

Get notified when new reports publish.

Free. We email when results are in, and nothing else.

Powered by MailerLite. No spam. Unsubscribe anytime.